Clinical Trial Update: Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) [Phase 2]

View source ↗

Summary

Phase 2 trial investigating levetiracetam for neuropsychiatric symptoms related to epilepsy in Alzheimer's disease patients; status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Walter Reed National Military Medical Center | Conditions: Alzheimer Disease | Phase 2 | Status: UNKNOWN